Navigation Links
Einstein secures $11 million to continue research on brain aging and Alzheimer's disease
Date:5/9/2011

May 9, 2011 (BRONX, NY) An estimated five million Americans have Alzheimer's disease. Health experts expect the number of cases to rise dramatically as the population ages reaching 13.5 million by 2050. Researchers at Albert Einstein College of Medicine of Yeshiva University are among those investigating the origins and treatments of this disabling disorder.

The Einstein Aging Study (EAS) , which examines both normal brain aging and the special challenges of Alzheimer's disease and other dementias, has recently received a renewal grant of $11 million from the National Institutes of Health's (NIH) National Institute on Aging (NIA) to continue its work. Richard B. Lipton, M.D., the Lotti and Bernard Benson Faculty Scholar in Alzheimer's Disease and professor and vice chair of The Saul R. Korey Department of Neurology, will continue to lead an interdisciplinary team of researchers and health care professionals working to discover dementia's causes and potential therapies.

"We are grateful for the longstanding support of this research program from the NIA and Einstein," said Dr. Lipton, who has been the director of EAS since 1992. "With this new funding, we will continue to explore the relationship between cognitive and motor aging and begin to study the role of pain and stress as well as disease in small blood vessels (microvascular disease) as novel, remediable risk factors for Alzheimer's disease."

Since its initial funding by the NIA 30 years ago, the EAS and its investigators have contributed to the understanding of brain aging by tracking over 2,000 Bronx County residents. Participants who join the EAS must be over 70 years old and meet regularly with researchers, who screen for a variety of physical and mental health indicators and track changes in brain function. Among their findings are that memory decline accelerates seven years before Alzheimer's disease becomes diagnosable. Armed with this knowledge, they are assessing biomarkers, genes and neuro-imaging procedures that will facilitate earlier diagnosis, prevention and treatment of Alzheimer's disease.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. NIH awards $10M to Einstein for diabetes research
2. Einstein awarded NIH grant to study drug-resistant TB
3. Einstein scientist awarded $4 million to develop genetic strategy to combat tuberculosis
4. Feinstein Institute to share $5M US Department of Defense grant
5. ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA
6. Einstein-Montefiore researcher will test nanoparticles against pancreatic cancer
7. Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research
8. Feinstein scientists identify abnormal disease pathway in dystonia
9. Einstein Montefiore lung specialist to receive award for work with 9/11 rescue workers
10. New York Law Firm Secures $750,000 Settlement for Bronx Man Injured in Slip and Fall Accident
11. Charlie Kimball Secures Partnership with Novo Nordisk, Maker of the Levemir FlexPen, for 2010 Firestone Indy Lights Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX editors ... said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes 30 ... drop zones. Editors can select from a variety of flip book animations. In Addition, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Bioelectronic ... Plus for consumers and healthcare professionals to manage chronic and acute pain. ... treatment modalities available in a single device. The announcement is part of ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... ... ... With God: Inspirational Lessons from My Life's Journey”: a sometimes serious, sometimes humorous ... in their lives. “Walking With God: Inspirational Lessons from My Life's Journey” is the ... , Sanford says, “I enjoy sharing the true stories in my book as examples ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... for individuals impacted by cerebral cavernous angiomas, was awarded a grant from the ... patient engagement program. New Mexico has more people with cavernous angioma than anywhere ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... The pen needles market is projected to ... billion in 2016, growing at a CAGR of 11.2% ... Over the years, the pen needles market has witnessed ... growing demand for safety injections in the healthcare industry. ... pen needles with an aim to reduce pain, increase ...
(Date:12/6/2016)... -- Nearly 30 million people in the United ... 1 However, nearly 40% of diabetes patients in ... significant glucose variability. 2 These patients are at high ... left untreated, hyperglycemia can lead to cardiovascular disease, nerve ... As part of Diabetes Awareness Month, ...
(Date:12/6/2016)... opioids commonly used for pain management for workplace injuries, employers now ... to nationwide fatalities. The synthetic opioid called U-47700, or ... morphine, resulting in likelihood of addiction, abuse or death. ... , , ... for HMC HealthWorks, explained the opioid drug is less expensive yet ...
Breaking Medicine Technology: